No Recovery, No Fee! Rosen Law Firm Explains Securities Class Action Lawsuits

Many investors have heard of 'securities class action lawsuits' but may not truly understand what they are—or how they can help. Today, we’ve compiled answers to several of the most frequently asked questions to help you quickly grasp the essentials👇 1️⃣ What is a securities class action lawsuit? 👉 In simple terms, it’s a legal mechanism whereby investors collectively sue a company for losses incurred due to corporate misconduct—such as false statements, financial fraud, or material misrepresentations in disclosures—that caused the stock price to drop. 2️⃣ What is the 'class period'? 👉 It refers to the timeframe during which the stock price was artificially inflated by false or misleading information. Only investors who purchased shares during this period—and subsequently suffered losses—may participate in the lawsuit and be eligible for compensation. 3️⃣ What is a 'lead plaintiff'? 👉 The lead plaintiff serves as the 'representative plaintiff,' appointed by the court to act on behalf of all injured investors and steer the litigation. While typically the investor with the largest financial loss, the ultimate recovery and settlement benefits all qualified members of the class. 4️⃣ Advantages of securities class action lawsuits ✔️ Investors avoid filing individual lawsuits—saving time and effort ✔️ Contingency-fee representation: no upfront legal fees or out-of-pocket costs ✔️ Even relatively small losses can be recovered collectively

Globally Respected Investor Counsel ROSEN Encourages Instadose Pharma Corp. (f/k/a Mikrocoze, Inc.) Investors Who Suffered Losses Exceeding $100,000 to Join the INSD/MZKR Securities Class Action Before the Critical Deadline

What this means: Individuals who purchased Instadose securities during the class period may recover compensation through a contingency-fee arrangement—with no out-of-pocket expenses or fees. What to do next: To join the Instadose class action, please visit http://www.rosenlegal.com/cases-register-2217.html, call toll-free at 866-767-3653, or email Phillip Kim, Esq., at pkim@rosenlegal.com or cases@rosenlegal.com for more information about the litigation. The law firm has already filed the class action complaint. If you wish to serve as lead plaintiff, you must apply to the court by February 28, 2022. The lead plaintiff acts as the representative party guiding the litigation on behalf of all other class members. Why choose ROSEN LAW: We urge investors to select qualified attorneys with a proven, documented track record of success in leadership roles. Law firms issuing such notices often lack comparable experience, resources, or rigorous peer recognition. Many such firms have never actually filed securities class actions. Please choose your legal counsel wisely. Rosen Law Firm serves investors worldwide, specializing in securities class actions and shareholder derivative litigation. Rosen Law Firm initiated the largest securities class action ever filed against a Chinese company—and successfully achieved a settlement. In 2017, Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements it secured. Since 2013, Rosen Law Firm has consistently ranked among the top four firms on that same list—and has recovered hundreds of millions of dollars for investors. In 2019 alone, the firm recovered over $438 million for investors. In 2020, founding partner Laurence Rosen was named a 'Titan of Plaintiffs’ Bar' by Law360.

Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Chemours - CC

Oct 15, 2026

ClaimsFiler notifies investors of the December 7, 2026 lead plaintiff deadline in a securities class action against Chemours, following a stock decline after the company cut its full-year adjusted EBITDA guidance.

StreetInsider

2026-04-17

Chemours' Fayetteville Works Earns Gold-Level WHC Conservation Certification for Environmental Excellence

2026-04-18

Chemours Company Receives Average 'Hold' Recommendation from Brokerages

2026-04-21

Chemours' West Virginia Forest Partnership Delivers Measurable Climate and Community Impact After Five Years

2026-04-21

Chemours to Release Q1 2026 Results May 5, Host Webcast

2026-04-22

Activists Demand No-Mining Pledge Near Okefenokee Swamp from Chemours